Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population; PSMAddition ...
There is no shortage of conversation about what AI can do. Every day brings a new headline, a new capability, a new ...
This press release is intended for public audiences. This material was created and funded by Novartis Pharmaceuticals UK Ltd. “The nature of CSU means that symptoms such as itching and burning rashes ...
Basel, April 4, 2019 - Novartis announced today that there is a legal dispute with Amgen regarding the collaboration agreements in the field of migraine. On April 2, 2019, Amgen issued a notice of ...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Country Head, Communications, Patient Advocacy, CSR and Business Excellence & Execution Sadhna Joglekar ...
Novartis believes all people with spinal muscular atrophy (SMA) – a rare, genetic, neuromuscular disease – should have access to gene therapy that addresses the root cause of their disease. This is ...
An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
The first pharmaceutical company to develop and manufacture innovative medicines in the history of the Slovenian pharmaceutical industry. With the support of advanced technologies, Novartis in ...
As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results